MN

Manali Namdeo

Director Director DIN 08423385
DIN 08423385 First appointment Apr 2019 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Apr 2019
Shareholding value Locked Premium profile

About Manali Namdeo

Data last updated:

Manali Namdeo has 7 years in corporate governance. Formerly with 1 company, such as Ceepax Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 08423385
Primary Designation Director
First Appointment 16 Apr 2019
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Ceepax Pharma Private Limited U74994MP2019PTC048371
Director16 Apr 20192019Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ceepax Pharma Private Limited
Premium access

Shareholding and investment profile for Manali Namdeo

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manali Namdeo

Manali Namdeo has 7 years in corporate governance. Formerly with 1 company, such as Ceepax Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Manali Namdeo is associated with 0 companies as a director.

Manali Namdeo has expertise in General Business.

Manali Namdeo has 7 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available